MICELL TECHNOLOGIES INC

Profile

Company Names

MICELL TECHNOLOGIES INC

Addresses

801 CAPITOLA DRIVE, SUITE 1, DURHAM, NC 27713

801 CAPITOLA DRIVE, SUITE1, DURHAM, NC 27713

7516 PRECISION DRIVE, SUITE 101, RALEIGH, NC 27617

Phone Numbers

919-313-2102

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$166,400,055.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2017-09-01 
$61,775,000.00 
$70,000,000.00 
$8,225,000.00 
Equity, Debt 
5
2017-06-16 
$41,775,000.00 
$50,000,000.00 
$8,225,000.00 
Equity, Debt 
4
2017-03-28 
$31,775,000.00 
$35,000,000.00 
$3,225,000.00 
Equity, Debt 
3
2016-06-20 
$25,775,000.00 
$30,000,000.00 
$4,225,000.00 
Equity, Debt 
2
2009-11-19 
$300,055.00 
$300,055.00 
$0.00 
Equity 
1
2009-07-17 
$5,000,000.00 
$5,300,000.00 
$300,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARTHUR 
J. 
BENEVENUTO 
EXECUTIVE OFFICER, DIRECTOR
ARTHUR 
BENVENUTO 
EXECUTIVE OFFICER, DIRECTOR
ARTHUR 
J. 
BENVENUTO 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
A. 
DRESNER 
DIRECTOR
DANIEL 
 
ESTAY 
EXECUTIVE OFFICER, DIRECTOR
INVEMED CATALYST 
 
FUND, L.P. 
PROMOTER
JACK 
 
HERMAN 
EXECUTIVE OFFICER
JAMES 
A. 
KLEIN 
EXECUTIVE OFFICER
JAMES 
A. 
KLEIN, JR. 
EXECUTIVE OFFICER
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
KENNETH 
LANGONE 
DIRECTOR
KENNETH 
G. 
LANGONE 
DIRECTOR
JAMES 
MCCLAIN 
EXECUTIVE OFFICER
TIMOTHY 
 
MCMAHON 
EXECUTIVE OFFICER
STEWART 
 
NOBLE, PH.D. 
EXECUTIVE OFFICER
GENERAL ELECTRIC 
 
PENSION TRUST 
PROMOTER
MICHAEL 
 
STANSKY 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-09-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-06-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-03-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-06-20 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-19 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2009-07-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
INVEMED ASSOCIATES LLC